Code
Listing of Patients with Study Drug Withdrawn Due to Adverse Events
————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
Date of First
Study Drug Study Day Discontinued
Treatment Center/Patient ID Age/Sex/Race Administration of Withdrawal Early from Study?
————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
A: Drug X RUS-18/id-359 47/F/BLACK OR AFRICAN AMERICAN 08JUN2019 1096 No
BRA-1/id-42 36/M/BLACK OR AFRICAN AMERICAN 01JAN2020 NA No
CHN-11/id-256 23/M/ASIAN 17MAR2020 1096 No
CHN-1/id-26 29/M/WHITE 16JUL2020 1096 No
CHN-1/id-62 36/F/WHITE 22NOV2020 455 Yes
B: Placebo CHN-7/id-28 40/M/AMERICAN INDIAN OR ALASKA NATIVE 11MAR2019 1096 No
CHN-13/id-102 37/M/ASIAN 23MAR2019 1096 No
CHN-3/id-333 30/F/BLACK OR AFRICAN AMERICAN 13JAN2020 NA No
USA-12/id-226 30/M/WHITE 29JAN2020 NA No
CHN-9/id-147 26/F/ASIAN 06FEB2020 NA No
USA-11/id-157 50/M/WHITE 14JUN2020 1096 No
CHN-9/id-11 28/F/NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER 27JAN2021 388 Yes
C: Combination CHN-15/id-262 35/M/BLACK OR AFRICAN AMERICAN 26FEB2019 1096 No
NGA-11/id-173 24/F/BLACK OR AFRICAN AMERICAN 10MAR2019 1096 No
CHN-11/id-263 34/F/ASIAN 03APR2019 1096 No
PAK-2/id-191 38/F/AMERICAN INDIAN OR ALASKA NATIVE 07APR2019 1096 No
USA-11/id-136 38/F/ASIAN 02OCT2019 865 Yes
CHN-17/id-31 35/F/ASIAN 17NOV2019 NA No
BRA-11/id-237 64/F/ASIAN 10MAR2020 1096 No
USA-11/id-100 40/F/ASIAN 10MAR2020 705 Yes